Olufunmilayo I. Olopade, M.D., FACP

Walter L. Palmer Distinguished Service Professor of Medicine & Human Genetics, The University of Chicago, Pritzker School of Medicine

Associate Dean for Global Health, The University of Chicago, Pritzker School of Medicine

Director, Center for Clinical Cancer Genetics, The University of Chicago, Pritzker School of Medicine

Olufunmilayo I. Olopade, M.D., FACP

Education:
University of Ibadan College of Medicine, Ibadan, Nigeria with Distinction in Pathology & Pediatrics
University College Hospital, Ibadan, Nigeria
Internship (1984) – Cook County Hospital of Chicago
Residency (1986) – Cook County Hospital of Chicago
University of Chicago, Pritzker School of Medicine

Bio:
Dr. Olopade is the Walter L. Palmer Distinguished Service Professor of Medicine and Associate Dean for Global Health at the University of Chicago Medical Center.

Dr. Olopade graduated with distinction from the University of Ibadan College of Medicine in Nigeria and completed her residency training in Internal Medicine at Cook County Hospital in Chicago, where she also served as Chief Resident. Trained broadly in clinical hematology/oncology and cancer genetics at the University of Chicago, Dr. s research interests are diverse and include treatment of breast cancer, especially in young or pregnant women; familial cancers; molecular genetics of cancer; cancer risk assessment and chemoprevention; breast cancer and minority populations; and disparities in health outcomes.

As a physician and scientist, Dr. Olopade works to translate scientific discoveries at the individual and population level into optimal interventions for women at risk of breast cancer. Dr. Olopade has a special interest in women of African descent, who are at higher risk for the more aggressive breast cancer and more likely to be diagnosed at a younger age; her research on this population has broadened our understanding of the complex interactions of genes, lifestyle, and the environment in breast cancer causation. She aims to develop new biomarkers and improve screening standards and early detection for moderate- and high-risk populations.

Dr. Olopade has received numerous honors and awards, including the James S. McDonnell Foundation Scholar Award, the Doris Duke Distinguished Clinical Scientist Award and the MacArthur “Genius Grant” Fellowship. She is a member of the Institute of Medicine of the National Academies and the American Philosophical Society, and she is a fellow of the American Academy of Arts and Sciences.

Dr. Olopade was appointed by President Barack Obama to serve on the National Cancer Advisory Board, the highest level board that oversees the activities of the National Cancer Institute. In this role, she shapes the national cancer program and the investments made by NCI.